Advanced Search
LUO Binrui, GUO Tianhong, HUANG Yuanshuai. Diagnostic Values of Salivary miRNA-21 for Early Laryngeal Squamous Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 2018, 45(5): 320-325. DOI: 10.3971/j.issn.1000-8578.2018.17.1137
Citation: LUO Binrui, GUO Tianhong, HUANG Yuanshuai. Diagnostic Values of Salivary miRNA-21 for Early Laryngeal Squamous Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 2018, 45(5): 320-325. DOI: 10.3971/j.issn.1000-8578.2018.17.1137

Diagnostic Values of Salivary miRNA-21 for Early Laryngeal Squamous Cell Carcinoma

More Information
  • Corresponding author:

    HUANG Yuanshuai, E-mail: hys@live.cn

  • Received Date: September 11, 2017
  • Revised Date: January 10, 2018
  • Available Online: January 12, 2024
  • Objective 

    To explore the diagnostic value of salivary miR-21 for patients with laryngeal squamous cell carcinoma(LSCC).

    Methods 

    We collected saliva samples from 20 LSCC patients, 15 vocal cord polyp patients and 15 healthy controls were collected. Real-time quantitative reverse transcription PCR was applied to compare the relative expression of miR-21. The changes of miRNA-21 in six LSCC patients before and six months after operation was compared through monitoring analysis.

    Results 

    The expression of salivary miRNA-21 in LSCC patients was significantly higher than that in healthy control group (P=0.036). The diagnostic value of miRNA-21 for LSCC by ROC curve analysis showed that the area under the curve (AUC) of the miRNA-21 in saliva was 0.792 (95%CI: 0.5353-0.885, P=0.036). The relative expression level of miRNA-21 was significantly decreased in six LSCC patients beforeand six months after operation(P=0.041).

    Conclusion 

    miRNA-21 is highly expressed in the saliva of patients with laryngeal squamous cell carcinoma, and it could be used as an indicator of early diagnosis of laryngeal squamous cell carcinoma in future.

  • [1]
    Landry D, Glastonbury CM. Squamous Cell Carcinoma of the Upper Aerodigestive Tract: A Review[J]. Radiol Clin North Am, 2015, 53(1): 81-97. doi: 10.1016/j.rcl.2014.09.013
    [2]
    Macneil SD, Liu K, Shariff SZ, et al. Secular trends in the survival of patients with laryngeal carcinoma, 1995–2007[J]. Curr Oncol, 2015, 22(2): e85-99. doi: 10.3747/co.22.2361
    [3]
    Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004, 116(2): 281-97. doi: 10.1016/S0092-8674(04)00045-5
    [4]
    Tong AW, Nemunaitis J. Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?[J]. Cancer Gene Ther, 2008, 15(6): 341-55. doi: 10.1038/cgt.2008.8
    [5]
    Cao P, Liang ZM, Jin Z, et al. Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma[J]. Head Neck, 2013, 35(5): 720-8. doi: 10.1002/hed.v35.5
    [6]
    Wang Y, Chen M, Tao Z, et al. Identification of predictive biomarkers for early diagnosis of larynx carcinoma based on microRNA expression data[J]. Cancer Genet, 2013, 206(9-10): 340-6. doi: 10.1016/j.cancergen.2013.09.005
    [7]
    Ayaz L, Görür A, Yaroǧlu HY, et al. Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma[J]. J Cancer Res Clin Oncol, 2013, 139(9): 1499-506. doi: 10.1007/s00432-013-1469-2
    [8]
    Wong DT. Salivary diagnostics[J]. Oper Dent, 2012, 37(6): 562-70. doi: 10.2341/12-143-BL
    [9]
    Denny P, Hagen FK, Hardt M, et al. The Proteomes of Human Parotid an Submandib- ular/Sublingual Gland Salivas Collected as the Ductal Secretions[J]. J Proteome Res, 2008, 7(5): 1994-2006. doi: 10.1021/pr700764j
    [10]
    Li Y, Zhou X, St John MA, et al. RNA profiling of cell-free saliva using microarray technology[J]. J Dent Res, 2004, 83(3):199-203. doi: 10.1177/154405910408300303
    [11]
    Wei J, Xie G, Zhou Z, et al. Salivary metabolite signatures of oral cancer and leukoplakia[J]. Int J Cancer, 2011, 129(9): 2207-17. doi: 10.1002/ijc.v129.9
    [12]
    Park NJ, Zhou H, Elashoff D, et al. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection[J]. Clin Cancer Res, 2009, 15(17): 5473-7. doi: 10.1158/1078-0432.CCR-09-0736
    [13]
    Cai EH, Gao YX, Wei ZZ, et al. Serum miR-21 expression in human esophageal squamous cell carcinomas[J]. Asian Pac J Cancer Prev, 2012, 13(4): 1563-7. doi: 10.7314/APJCP.2012.13.4.1563
    [14]
    Han JG, Jiang YD, Zhang CH, et al. A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer[J]. An Sur Treat Res, 2017, 92(2): 55-66. doi: 10.4174/astr.2017.92.2.55
    [15]
    Correa-Gallego C, Maddalo D, Doussot A, et al. Circulating plasma levels of microrna-21 and microrna-221 are potential diagnostic markers for primary intrahepatic cholangiocarcinoma[J]. PLoS One, 2016, 11(9): e0163699. doi: 10.1371/journal.pone.0163699
    [16]
    Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method[J]. Methods, 2001, 25(4): 402-8. doi: 10.1006/meth.2001.1262
    [17]
    Zhang L, Farrell JJ, Zhou H, et al. Salivary Transcriptomic biomarkers for detection of resectable pancreatic cancer[J]. Gastroenterology, 2010, 138(3): 949-57. doi: 10.1053/j.gastro.2009.11.010
    [18]
    Gursoy UK, Könönen E, Uitto VJ, et al. Salivary interleukin-1beta concentration and the presence of multiple pathogens in periodontitis[J]. J Clin Periodontol, 2009, 36(11): 922-7. doi: 10.1111/cpe.2009.36.issue-11
    [19]
    Jyoti B, Devi P. Detection of human immunodeficiency virus using oral mucosal transudate by rapid test[J]. Indian J Sex Transm Dis, 2013, 34(2): 95-101. doi: 10.4103/0253-7184.120539
    [20]
    Centers for Disease Control and Prevention (CDC). Approval of a new rapid test for HIV antibody[J]. MMWR Morb Mortal Wkly Rep, 2002, 51(46): 1051-2. https://www.ncbi.nlm.nih.gov/pubmed/12487529
    [21]
    Salazar C, Nagadia R, Pandit P, et al. A novel saliva-based microRNA biomarker panel to detect head and neck cancers[J]. Cell Oncol(Dordr), 2014, 37(5): 331-8. doi: 10.1007/s13402-014-0188-2
    [22]
    叶敏华, 叶鹏辉, 张伟珠, 等.唾液与血浆微小RNA-21对早期食管癌的诊断价值[J].南方医科大学学报, 2014, 34(6): 885-9. http://www.cqvip.com/QK/91170A/201406/50044665.html

    Ye MH, Ye PH, Zhang WZ, et al. Diagnostic values of salivary versus and plasma microRNA-21 for early esophageal cancer[J]. Nan Fang Yi Ke Da Xue Xue Bao, 2014, 34(6): 885-9. http://www.cqvip.com/QK/91170A/201406/50044665.html
    [23]
    Patel RS, Jakymiw A, Yao B, et al. High resolution of microRNA signatures in human whole saliva[J]. Arch Oral Biol, 2011, 56(12): 1506-13. doi: 10.1016/j.archoralbio.2011.05.015
    [24]
    Wang J, Zhou Y, Lu J, et al. Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma[J]. Medi Oncol, 2014, 31(9): 148. doi: 10.1007/s12032-014-0148-8
    [25]
    Huang Y, Yang YB, Zhang XH, et al. MicroRNA-21 gene and cancer[J]. Medi Oncol, 2013, 30(1): 376. doi: 10.1007/s12032-012-0376-8
    [26]
    Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients[J]. Nat Rev Cancer, 2011, 11(6): 426-37. doi: 10.1038/nrc3066
  • Related Articles

    [1]LU Hui, XIE Zhengyuan. Research Progress in Noninvasive Early Diagnosis of Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2023, 50(1): 75-80. DOI: 10.3971/j.issn.1000-8578.2023.22.0642
    [2]ZANG Yi, WANG Lifu. Progress of miRNAs Related to Pancreatic Cancer[J]. Cancer Research on Prevention and Treatment, 2016, 43(11): 996-1000. DOI: 10.3971/j.issn.1000-8578.2016.11.015
    [3]Fu Weijin, Mi Hua, Liu Deyun, Yan Haibiao, Huang Weihua, Mo Zengnan. Diagnosis and Treatment of Adrenal Schwannoma[J]. Cancer Research on Prevention and Treatment, 2013, 40(01): 87-89. DOI: 10.3971/j.issn.1000-8578.2013.01.022
    [4]FAN Guo-yu, WU Xiao-kui, LI Chun-guo. Diagnosis Value of Tumor Markers for Malignant Pleural Effusions[J]. Cancer Research on Prevention and Treatment, 2011, 38(04): 434-436. DOI: 10.3971/j.issn.1000-8578.2011.04.018
    [5]WU Guo-cheng, HU Hua-cheng, SHI Min-hua. Value of Serum ADAM8 Level in Diagnosis of Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2009, 36(08): 679-681. DOI: 10.3971/j.issn.1000-8578.2009.08.014
    [6]WU Bin, QIU Hui zhong, ZHOU Xu dong, CUI Quan cai, GUAN Jing hong, LIN Guo le, ZHAO Yu pei. The Diagnosis and Surgical Treatment of Malignant Gastric Stromal Tumors[J]. Cancer Research on Prevention and Treatment, 2004, 31(11): 697-699. DOI: 10.3971/j.issn.1000-8578.2080
    [7]QU Hong-yan, PANG DA, XUE Ying-wei, et al, . Diagnosis and treatment of spleen tumor[J]. Cancer Research on Prevention and Treatment, 2002, 29(04): 316-316. DOI: 10.3971/j.issn.1000-8578.3303
    [8]HUANG ZHao-sui, WANG Yi-ming, HUANG CHun-hong, et al, . The application of TSGF test in the diagnosis of carcinosis[J]. Cancer Research on Prevention and Treatment, 2002, 29(03): 215-216. DOI: 10.3971/j.issn.1000-8578.1552
    [9]CAI Xiao-qing, LI Wen-guang. The diagnosis and treatment of the bladder mixed tumor[J]. Cancer Research on Prevention and Treatment, 2002, 29(02): 133-134. DOI: 10.3971/j.issn.1000-8578.941
    [10]Lu Guangsheng, Dou Kefeng, Li Kaizhong, . Diagnosis and Surgical Treatment Extrahepatic of Cholangiocarcinoma[J]. Cancer Research on Prevention and Treatment, 1999, 26(2): 127-128.

Catalog

    Article views (1877) PDF downloads (444) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return